Details for Patent: 9,764,003
✉ Email this page to a colleague
Which drugs does patent 9,764,003 protect, and when does it expire?
Patent 9,764,003 protects WEGOVY and is included in one NDA.
This patent has twenty-four patent family members in fifteen countries.
Summary for Patent: 9,764,003
| Title: | Use of long-acting GLP-1 peptides |
| Abstract: | The invention relates to use of long-acting GLP-1 peptides in certain dosage regimes for the treatment of type 2 diabetes, obesity, etc. |
| Inventor(s): | Jensen; Christine B. (Charlottenlund, DK) |
| Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
| Application Number: | 14/409,493 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 9,764,003
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-001 | Jun 4, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD FOR WEIGHT MANAGEMENT ACCORDING TO A DOSE ESCALATION SCHEDULE | ⤷ Try a Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-002 | Jun 4, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD FOR WEIGHT MANAGEMENT ACCORDING TO A DOSE ESCALATION SCHEDULE | ⤷ Try a Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-003 | Jun 4, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD FOR WEIGHT MANAGEMENT ACCORDING TO A DOSE ESCALATION SCHEDULE | ⤷ Try a Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-004 | Jun 4, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD FOR WEIGHT MANAGEMENT ACCORDING TO A DOSE ESCALATION SCHEDULE | ⤷ Try a Trial | ||||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-005 | Jun 4, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHOD FOR WEIGHT MANAGEMENT ACCORDING TO A DOSE ESCALATION SCHEDULE | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,764,003
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 12174535 | Jul 1, 2012 | |
| 12186781 | Oct 1, 2012 | |
| PCT Information | |||
| PCT Filed | June 21, 2013 | PCT Application Number: | PCT/EP2013/063004 |
| PCT Publication Date: | January 09, 2014 | PCT Publication Number: | WO2014/005858 |
International Family Members for US Patent 9,764,003
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013286177 | ⤷ Try a Trial | |||
| Australia | 2018202504 | ⤷ Try a Trial | |||
| Australia | 2020202573 | ⤷ Try a Trial | |||
| Brazil | 112014032938 | ⤷ Try a Trial | |||
| Canada | 2877056 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
